AKOUOS RAISES $50 MILLION SERIES A FINANCING AND EXPANDS TEAM TO ADVANCE PRECISION GENETIC THERAPIES
Boston, Mass. – August 7, 2018 – Akouos, a precision genetic medicine company developing gene therapies that restore and preserve hearing, today announced the Company has raised $50 million in Series A financing. Seed investors 5AM Ventures and New Enterprise Associates (NEA) co-led the round, and were joined by existing seed investor Partners Innovation Fund and new investors Sofinnova Ventures, RA Capital Management and Novartis Venture Fund.
Printed from https://innovationblog.partners.org/kouos-raises-50-million-series-a-financing-and-expands-team-to-advance-precision-genetic-therapies-that-restore-and-preserve-hearing · Published 07 Nov 2018
© PARTNERS HEALTHCARE. ALL RIGHTS RESERVED